Trial intelligence / Profile preview

Intrathecal baclofen in dystonic cerebral palsy

NL-OMON21127Active, not recruiting

Sponsor
Vrije University Medical Center
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in dyskinetic cerebral palsy (DCP) and dystonic cerebral palsy comparing Continuous intrathecal baclofen with Placebo via implanted pump (2 arms). Primary endpoint: Effect on daily functioning and daily care. Started Jan 2013; status: active, not recruiting.

02

Drugs

baclofen
03

Conditions

dyskinetic cerebral palsy (DCP)dystonic cerebral palsy

Beyond the preview

Go deeper on NL-OMON21127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call